GSK Pharma forays into gynaecological cancer treatment in India

GlaxoSmithKline Pharmaceuticals Ltd. stock zoomed as much as 2% on Monday, August 25. This movement in shares came after the company announced its entry into the oncology segment in India with Jemperli and Zejula therapies that can be used for the treatment of gynaecological cancers.

At around 2.14 PM, GSK Pharma was trading 0.28% higher at ₹2,806.70 per piece, against the previous close of ₹2,798.80 on NSE. The counter touched an intraday high and low of ₹2,869, and ₹2,797.50, respectively.

Jemperli is one and only approved programmed death receptor-1 (PD-1) immunotherapy. This will be used for the second-line treatment of mismatch repair-deficient (dMMR)/microsatellite instability-high advanced or recurrent endometrial cancer, in India.

This therapy blocks the PD-1 pathway. This is a mechanism that is used by cancer cells to evade immune detection, hence allowing immune cells to recognise and attack the tumor more effectively, informed the company in its filing with the bourses.

Additionally, Zejula is the only PARP (Poly(ADP-ribose) polymerase) inhibitor approved. This will be first-line monotherapy maintenance for all biomarker types in advanced ovarian cancer in India, the company informed.

GSK also informed that it is planning to unveil a patient support programme for empowerment of patients to access these innovative therapies.

Related Posts

Without Skipping a Beat: Surgical Robot SSiMantra powers Landmark Beating Heart Bypass

World’s 1st Dual Console Complex Robotic Beating Heart TECAB performed in India’   New Delhi: SSiMantra, the only ‘Made in India’ best in class surgical robot is as usual always…

Drug Department Raids Patna’s Govind Mitra Road Medicine Market Over Suspected Illegal Sale Of Medicines

Three teams inspected several wholesale medicine shops following complaints of sales without bills, storage irregularities and alleged illegal trading of government-supplied medicines. Patna: The Drug Department has launched an inspection…

Leave a Reply

Your email address will not be published. Required fields are marked *

You Missed

Without Skipping a Beat: Surgical Robot SSiMantra powers Landmark Beating Heart Bypass

Without Skipping a Beat: Surgical Robot SSiMantra powers Landmark Beating Heart Bypass

Drug Department Raids Patna’s Govind Mitra Road Medicine Market Over Suspected Illegal Sale Of Medicines

Drug Department Raids Patna’s Govind Mitra Road Medicine Market Over Suspected Illegal Sale Of Medicines

‘Forthwith’ Under Drugs Act Does Not Mean Immediate Dispatch of Seized Drug Samples: Karnataka HC

‘Forthwith’ Under Drugs Act Does Not Mean Immediate Dispatch of Seized Drug Samples: Karnataka HC

A Worthy New Leader takes the Torch @Sir Ganga Ram Hospital

A Worthy New Leader takes the Torch @Sir Ganga Ram Hospital

CBI arrests two NCB staffers for demanding Rs 25 lakh bribe from a chemist in UP

CBI arrests two NCB staffers for demanding Rs 25 lakh bribe from a chemist in UP

Delhi Police bust fake Unani healthcare call centre in Pitampura; 12 arrested

Delhi Police bust fake Unani healthcare call centre in Pitampura; 12 arrested